R.I. Lopez
Impact in
-
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 5
- HER2/EGFR in Cancer Research 4
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 1
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- David Cameron (2 shared papers)Juan Carlos Alcedo (2 shared papers)Cheng S. Quah (2 shared papers)Carlos Bais (2 shared papers)Stanislas Hubeaux (2 shared papers)Igor Bondarenko (2 shared papers)David Miles (1 shared paper)Jungsil Ro (1 shared paper)
- Journals
- European Journal of Cancer (2 papers)Annals of Oncology (1 paper)Journal of Thoracic Oncology (1 paper)Clinical Oncology (1 paper)ESMO Open (1 paper)
- Partner nations
- SwitzerlandRussiaSouth Korea
In The Last Decade
R.I. Lopez
7 papers receiving 165 citations
Peers
Comparison fields: 5 of 44
- Oncology 117
- Cancer Research 52
- Ecology, Evolution, Behavior and Systematics 25
- Pulmonary and Respiratory Medicine 37
- Hepatology 8
Countries citing papers authored by R.I. Lopez
This map shows the geographic impact of R.I. Lopez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.I. Lopez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.I. Lopez more than expected).
Fields of papers citing papers by R.I. Lopez
This network shows the impact of papers produced by R.I. Lopez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.I. Lopez. The network helps show where R.I. Lopez may publish in the future.
Co-authors
The 25 scholars most cited alongside R.I. Lopez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 92 | |
| 2 | [A zinc sulfate and usnic acid preparation used as post-surgical adjuvant therapy in genital lesions by Human Papillomavirus]. | 1999 | 31 |
| 3 | 2013 | 24 | |
| 4 | 2018 | 10 | |
| 5 | 2015 | 7 | |
| 6 | 2012 | 5 | |
| 7 | 2014 | 1 | |
| 8 | 2016 | 0 |
About R.I. Lopez
R.I. Lopez is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Ecology, Evolution, Behavior and Systematics, having authored 8 papers that have together received 170 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (4 papers), Cancer Treatment and Pharmacology (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Smoking Behavior and Cessation (1 paper), School Health and Nursing Education (1 paper), Breast Cancer Treatment Studies (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Genetic factors in colorectal cancer (1 paper). The work is most often cited by research in Oncology (117 citations), Cancer Research (52 citations), Ecology, Evolution, Behavior and Systematics (25 citations), Pulmonary and Respiratory Medicine (37 citations) and Hepatology (8 citations). R.I. Lopez has collaborated with scholars based in Switzerland, Russia and South Korea. Frequent co-authors include David Cameron, Juan Carlos Alcedo, Cheng S. Quah, Carlos Bais, Stanislas Hubeaux, Igor Bondarenko, David Miles, Jungsil Ro, Seock‐Ah Im and Yaroslav Shparyk. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Journal of Thoracic Oncology, Clinical Oncology and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.